The information on this website is not intended for diagnosis or treatment. Please consult your physician for health concerns.

Skip to main content

Large Vestibular Aqueduct Syndrome (LVAS) — Pediatric Sensorineural Hearing Loss

Most common radiologically identifiable cause of pediatric sensorineural hearing loss; defined as vestibular aqueduct midpoint diameter >1.5 mm or operculum diameter >2 mm on temporal bone CT, frequently associated with SLC26A4 (pendrin) gene mutations and Pendred syndrome; presents with progressive or fluctuating sensorineural hearing loss, often triggered by minor head trauma, with treatment focused on hearing aids, cochlear implantation for severe loss, and avoidance of activities that cause head trauma.

Written by: Saygı Hospital Health Guide Editorial Board
Last updated:

This content has been compiled by the Saygı Hospital Health Guide Editorial Board and is periodically reviewed by a specialist physician.

References (5)

This content is for informational purposes only and does not constitute medical advice. You can book an appointment at our KBB (Kulak Burun Boğaz) department. Book Appointment →

What is Large Vestibular Aqueduct Syndrome (LVAS) — Pediatric Sensorineural Hearing Loss?

Large vestibular aqueduct syndrome (LVAS), or enlarged vestibular aqueduct (EVA), is the most common radiographically identifiable inner ear malformation associated with childhood sensorineural hearing loss, accounting for 5–15 percent of pediatric SNHL cases. The vestibular aqueduct is a bony channel within the petrous temporal bone running from the medial wall of vestibule of inner ear to the posterior cranial fossa, encasing the endolymphatic duct that connects the endolymphatic sac (located within dura mater) to the membranous labyrinth.

Cincinnati criteria define LVAS as midpoint diameter >1.5 mm or operculum diameter >2 mm on axial high-resolution temporal bone CT. Alternative criteria propose midpoint >0.9 mm or any vestibular aqueduct larger than adjacent posterior semicircular canal as enlarged. Bilateral involvement in 50–94 percent (asymmetric in many). Frequently associated with cochlear malformations, particularly incomplete partition type II (Mondini malformation — 1.5 turns of cochlea instead of 2.5).

Genetics: strong association with SLC26A4 gene (chromosome 7q22.3) encoding pendrin, a chloride-iodide-bicarbonate anion exchanger. Biallelic SLC26A4 mutations cause Pendred syndrome (autosomal recessive), characterized by sensorineural hearing loss, thyroid goiter (often appearing in adolescence), and abnormal organification of iodide demonstrable by positive perchlorate discharge test. Monoallelic SLC26A4 mutations or biallelic with EPHA2 modifier cause non-syndromic EVA (DFNB4 locus). Other associations: branchio-oto-renal (BOR) syndrome (EYA1, SIX5 mutations), CHARGE syndrome, distal renal tubular acidosis, X-linked deafness with stapes gusher (POU3F4).

Hearing loss characteristics: bilateral in most, often asymmetric, sensorineural (rarely conductive component due to third window effect), ranges from mild to profound, may be present at birth (congenital — fail newborn hearing screening), or develop later (delayed onset). Course: progressive in 50 percent (gradual decline over months to years), fluctuating in 10–35 percent (recovers partially or fully), or sudden drops triggered by: minor head trauma (most common — fall, sports injury, even hitting head on cabinet), barotrauma (scuba diving, airplane descent), Valsalva (heavy lifting, straining), vigorous exercise, or upper respiratory infection. Vestibular symptoms (vertigo, imbalance, motion intolerance) in 30 percent.

Symptoms

Bilateral or asymmetric sensorineural hearing loss, often progressive or fluctuating
Sudden hearing drops following minor head trauma, falls, or vigorous activity
Failed newborn hearing screening or delayed-onset hearing loss in childhood
Speech and language delay in toddlers
Vertigo, imbalance, motion intolerance (in 30 percent)
Tinnitus (high-frequency, often bilateral)
Aural fullness or pressure
Thyroid goiter appearing in adolescence (Pendred syndrome)
Family history of hearing loss with consanguinity (autosomal recessive)
Recurrent vertigo episodes mimicking Meniere disease (in older patients)

Risk Factors

SLC26A4 mutations (biallelic for Pendred, monoallelic for non-syndromic EVA)
Family history of progressive or fluctuating childhood hearing loss
Consanguineous parents (autosomal recessive Pendred syndrome)
Pendred syndrome features (goiter in adolescence, hypothyroidism)
BOR syndrome (preauricular pits, branchial cysts, renal anomalies)
CHARGE syndrome features (coloboma, heart defects, atresia choanae)
X-linked stapes gusher (males with mixed hearing loss)
Distal renal tubular acidosis with sensorineural hearing loss
Failed newborn hearing screening
History of minor head trauma followed by hearing drop

When to See a Doctor?

If you experience any of the following symptoms, seek medical attention promptly:

  • Failed newborn hearing screening — refer to pediatric audiology and ENT
  • Speech and language delay in toddler — comprehensive audiologic evaluation
  • Sudden hearing drop following minor head trauma in child — emergent
  • Progressive or fluctuating hearing loss in child — temporal bone imaging
  • Family history of hearing loss with new pediatric symptoms
  • Thyroid goiter appearing in adolescent with hearing loss (Pendred)
  • Vertigo or imbalance episodes in child with hearing loss
  • Concerns about activity restrictions in child with confirmed LVAS
  • Hearing loss progression despite hearing aids — cochlear implantation evaluation

Treatment Methods

01
Diagnostic workup: comprehensive audiologic evaluation (pure tone audiometry, speech audiometry, auditory brainstem response in young children, otoacoustic emissions, tympanometry; serial monitoring every 6–12 months for progression), high-resolution temporal bone CT (gold standard for vestibular aqueduct measurement, assesses cochlear and labyrinthine malformations including Mondini), MRI with FIESTA/CISS sequences (assesses endolymphatic duct and sac, cochlear nerve presence, associated brain anomalies), vestibular testing if symptoms (VEMPs, VNG)
02
Genetic and metabolic workup: SLC26A4 gene sequencing (Pendred and DFNB4), EYA1, SIX5 (BOR syndrome), POU3F4 (X-linked stapes gusher), CHD7 (CHARGE syndrome), perchlorate discharge test for thyroid organification (Pendred), thyroid ultrasound, TSH-T3-T4-thyroglobulin-anti-thyroid antibodies, urinalysis and renal function for distal RTA
03
Activity modification (cornerstone of management): strict avoidance of contact and collision sports (football, hockey, boxing, rugby, basketball), avoidance of head trauma (cabinet edges, falls), helmet during cycling-skating-skiing-skateboarding, avoidance of barotrauma (scuba diving — absolute contraindication; commercial flights generally safe), avoidance of heavy weight lifting and Valsalva-inducing activities, education of family-school-coaches about restrictions
04
Hearing aids (moderate to severe SNHL): bilateral behind-the-ear (BTE) digital aids with appropriate gain and compression, FM-DM system in classroom, cochlear implant evaluation when hearing aids no longer provide adequate benefit (severe-profound loss with HINT scores <50 percent in best-aided condition)
05
Cochlear implantation for severe-profound bilateral SNHL: excellent outcomes equivalent to or better than other etiologies of pediatric SNHL; bilateral cochlear implantation increasingly recommended for binaural hearing benefit; gusher (CSF efflux from oval window) reported in 10 percent due to enlarged cochlear modiolus or incomplete partition — managed with packing; avoid stapedectomy (gusher risk); careful surgical technique with slow electrode insertion to avoid further damage
06
Pendred syndrome management: endocrinology referral for thyroid surveillance (annual TFTs starting age 7–10; ultrasound for goiter), levothyroxine if hypothyroidism develops, thyroid surgery for cosmetically or compressively significant goiter; iodine replacement may help thyroid function (controversial)
07
Vestibular rehabilitation: vestibular therapy for chronic imbalance, fall prevention, gaze stabilization exercises, habituation training
08
Educational support: IEP (Individualized Education Program) accommodations, FM systems, preferential seating, deaf education services if profound loss, cochlear implant teacher of the deaf, sign language instruction option for some families
09
Genetic counseling: autosomal recessive (Pendred) — 25 percent recurrence risk for siblings; non-syndromic — depends on inheritance pattern; siblings should have audiologic evaluation
10
Long-term: lifelong audiologic surveillance with annual monitoring (more frequently if fluctuating), thyroid surveillance for Pendred, cochlear implant follow-up with regular mapping adjustments and rehabilitation, multidisciplinary team coordination (audiology, ENT, genetics, endocrinology, speech therapy, education)

Which Department to Visit?

You can visit our KBB (Kulak Burun Boğaz) department for these complaints. Our specialist physicians will create the most suitable treatment plan for you.

Learn About KBB (Kulak Burun Boğaz) Department

Let us help you

You can make an appointment with our specialists or contact us for your concerns.

Related Health Topics

Other articles from the same department you may want to explore.

Anaemia

Dahiliye (İç Hastalıkları)

Anaemia is a low haemoglobin level that reduces oxygen delivery, causing fatigue, pallor, and shortness of breath. It is not a disease itself but a sign of many underlying conditions. Most cases are correctable with appropriate diagnosis and treatment.

Iron Deficiency Anaemia

Dahiliye (İç Hastalıkları)

Iron deficiency anaemia develops when dietary intake, absorption, or losses create an iron shortfall, most often affecting women and children. Identifying the underlying cause is the core of management, alongside iron replacement.

Vitamin B12 Deficiency

Dahiliye (İç Hastalıkları)

Vitamin B12 deficiency can cause megaloblastic anaemia, neurological symptoms, and cognitive impairment. Early treatment with intramuscular or oral B12 largely prevents irreversible complications.

Hypertension (High Blood Pressure) Management

Dahiliye (İç Hastalıkları)

Hypertension is often called the silent killer because it progresses symptom-free for years and can damage the heart, brain, kidneys, and eyes. Regular monitoring, lifestyle change, and evidence-based drug therapy dramatically reduce cardiovascular risk.

Chronic Kidney Disease

Dahiliye (İç Hastalıkları)

Chronic kidney disease is one of the most common complications of chronic conditions such as diabetes and hypertension, and can be silent in its early stages.

Hepatitis B (HBV)

Dahiliye (İç Hastalıkları)

Hepatitis B is a DNA virus infection causing acute and chronic hepatitis with risk of cirrhosis and hepatocellular carcinoma; diagnosis integrates HBsAg, HBeAg, anti-HBc, and HBV DNA with management based on disease phase using nucleos(t)ide analogues (entecavir, tenofovir) and universal infant vaccination.

Hepatitis C (HCV)

Dahiliye (İç Hastalıkları)

Hepatitis C is an RNA virus causing chronic hepatitis that may progress to cirrhosis and hepatocellular carcinoma; modern direct-acting antiviral (DAA) pangenotypic regimens (sofosbuvir/velpatasvir, glecaprevir/pibrentasvir) achieve sustained virologic response over 95% in 8–12 weeks with universal adult screening and cure for nearly all patients.

Fatty Liver Disease

Dahiliye (İç Hastalıkları)

Non-alcoholic fatty liver disease (NAFLD) is closely related to obesity and metabolic syndrome and is largely reversible with early treatment.

Health Disclaimer: The information on this page is prepared for general informational purposes only. It does not replace medical diagnosis and treatment. Please consult your physician for your complaints. Saygı Hospital does not accept responsibility for actions taken based on the information on this page.